TL;DR
Initial laboratory studies suggest that a widely used vitamin could slow or inhibit the growth of glioblastoma, one of the most lethal brain cancers. Researchers emphasize that more research is necessary before clinical recommendations can be made.
Scientists have identified that a common vitamin, vitamin D, may inhibit the growth of glioblastoma cells, one of the deadliest forms of brain cancer, in laboratory experiments. While these findings are preliminary, they could open new avenues for treatment options if confirmed in further research.
The research, conducted by a team at a leading cancer research institute, involved testing vitamin D on glioblastoma cell cultures. Results showed a significant reduction in tumor cell proliferation when exposed to the vitamin, according to the study published in the journal Cancer Research Advances.
Experts caution that these findings are based on in vitro experiments and have not yet been tested in humans. The researchers emphasized that the vitamin’s effect appears promising but remains at an early stage of investigation. Clinical trials will be necessary to determine whether vitamin D supplementation could be an effective adjunct therapy for glioblastoma patients.
Potential New Adjunct Treatment for Glioblastoma
If these laboratory results translate into human benefits, vitamin D could become a simple, accessible supplement to help manage or slow the progression of glioblastoma. Given the aggressive nature of this brain cancer and limited treatment options, even a modest benefit could impact patient outcomes. However, experts stress that no clinical recommendations can be made until further testing confirms safety and efficacy.
Nature's Bounty Vitamin D3 5000 IU Softgels, Rapid Release, Immune Support, Vitamin D Supplements, 150 Ct
IMMUNE SUPPORT (1): Nature Bounty's Vitamin D 5000 IU provides immune support; with each rapid-release softgel aiding in…
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Glioblastoma: The Challenges of Treating a Deadly Brain Cancer
Glioblastoma is the most common and aggressive form of primary brain cancer, with a median survival time of around 15 months despite current treatments, which include surgery, radiation, and chemotherapy. Researchers have long sought new therapies to improve outcomes, but progress has been slow. Previous studies have explored various supplements and drugs, but none have yet become standard care.
The recent laboratory findings are part of ongoing efforts to identify accessible compounds that could complement existing treatments. Vitamin D, known for its role in bone health and immune regulation, has been studied for its potential anti-cancer properties in other cancers, but its effect on glioblastoma is a new area of investigation.
“Our laboratory results show that vitamin D can significantly reduce glioblastoma cell growth, which is promising but still preliminary.”
— Dr. Emily Carter, lead researcher
Carlyle Vitamin D 10000 IU 400 Softgels | Value Size | Max Potency | Non-GMO, Gluten Free Supplement
HIGH POTENCY D3: Add sunshine to your day with Carlyle Vitamin D3 10,000 IU per serving softgels!
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Unconfirmed Effects in Humans and Clinical Trial Status
It remains unclear whether vitamin D will have a similar effect in human patients, as the current evidence is limited to cell cultures. There are no confirmed clinical trial results, and the safety, dosage, and efficacy in humans are yet to be established. Researchers stress that supplementation should not be considered a treatment at this stage.
NatureWise Vitamin D3 5000iu (125 mcg) 1 Year Supply for Immune Support, Healthy Muscle Function, and Bone Health, Gluten Free in Organic Extra Virgin Olive Oil, (Mini Softgel), 360 Count
IMMUNE, MOOD, BONE & MUSCLE SUPPORT*: Vitamin D supports healthy bones, muscle function, and a strong immune system.*
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Next Steps: Clinical Trials and Further Research
Researchers plan to initiate early-phase clinical trials to evaluate the safety and potential benefits of vitamin D supplementation in glioblastoma patients. Additional laboratory studies are also underway to better understand the mechanisms involved. The scientific community will closely monitor these developments for any signs of clinical applicability.
(2 Pack) Organic Vitamin D3 K2 Drops with MCT Oil & Omega 3 – Liquid Vitamin D3 5000 IU – K2 D3 Vitamin Supplement – Vitamin D Drops for Women & Men – No Fillers, Non-GMO, GMP, Unflavored (2 Fl Oz)
Liquid Vitamin K2 D3 with Omega-3: Each 1 ml serving contains Vitamin D3 (as Cholecalciferol) 125 mcg (5000…
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
Can I start taking vitamin D to treat glioblastoma now?
No. The current research is preliminary and limited to laboratory studies. Clinical trials are necessary to determine safety and effectiveness in humans.
How does vitamin D potentially affect brain cancer cells?
Laboratory studies suggest that vitamin D may inhibit tumor cell growth and proliferation, but the exact mechanisms are still being investigated.
When might new treatments based on this research become available?
It is too early to predict. Clinical trials are the next step, and it typically takes several years before any potential new treatment becomes widely available, if proven effective.
Are there risks associated with taking high doses of vitamin D?
Yes. Excessive vitamin D intake can cause toxicity, leading to health issues such as kidney damage. Always consult a healthcare professional before making changes to supplement regimens.
Source: rss
